Fresenius Medical Care Corporation (FMS)

Official site

HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

$23.40

-0.26 (-1.10%)

Market Cap: $12.04B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

63%(26/41)

Avg Surprise

+7.06%

Streak

2 Q

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$0.55

Range$0.41 - $0.69

4 analysts

Revenue Consensus

$5.2B

Range$4.7B - $5.8B

17 analysts

Last 12 of 41 reported quarters and 1 upcoming estimate

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.55	$0.41 - $0.69	-	-	4	-	-
Sep 30, 2026Sep 26 Reported Nov 3, 2026Reported Nov 3	$0.64	$0.53	$0.51 - $0.55	+20.75%	Beat	2	1 0 30d	+16.4%
Jun 30, 2026Jun 26 Reported Aug 3, 2026Reported Aug 3	$0.66	$0.50	$0.45 - $0.55	+32.00%	Beat	2	1 1 30d	+43.5%
Mar 31, 2026Mar 26 Reported May 5, 2026Reported May 5	$0.46	$0.53	$0.47 - $0.53	-13.58%	Miss	2	0 1 30d	+8.3%
Dec 31, 2025Dec 25 Reported Feb 24, 2026Reported Feb 24	$0.72	$0.55	$0.44 - $0.67	+30.91%	Beat	2	1 0 30d	+58.2%
Sep 30, 2025Sep 25 Reported Nov 4, 2025Reported Nov 4	$0.55	$0.50	$0.48 - $0.53	+10.00%	Beat	2	1 0 30d	+34.1%
Jun 30, 2025Jun 25 Reported Aug 5, 2025Reported Aug 5	$0.46	$0.47	$0.45 - $0.48	-2.13%	Miss	2	1 0 30d	+31.4%
Mar 31, 2025Mar 25 Reported May 6, 2025Reported May 6	$0.42	$0.38	$0.29 - $0.48	+10.53%	Beat	2	No revisions (30d)	+31.2%
Dec 31, 2024Dec 24 Reported Feb 25, 2025Reported Feb 25	$0.46	$0.40	$0.37 - $0.43	+13.61%	Beat	2	1 0 30d	+3.4%
Sep 30, 2024Sep 24 Reported Nov 5, 2024Reported Nov 5	$0.41	$0.35	$0.35 - $0.35	+17.14%	Beat	1	No revisions (30d)	+46.4%
Jun 30, 2024Jun 24 Reported Jul 30, 2024Reported Jul 30	$0.35	$0.34	$0.33 - $0.35	+2.94%	Beat	2	1 0 30d	+16.7%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$0.32	$0.25	$0.25 - $0.28	+28.00%	Beat	2	1 0 30d	+23.1%
Dec 31, 2023Dec 23 Reported Feb 20, 2024Reported Feb 20	$0.44	$0.30	$0.29 - $0.31	+46.67%	Beat	2	No revisions (30d)	+83.3%

Dividends

Last ex-dividend: May 22, 2026

Dividend Metrics

Forward Yield3.72%

Forward Annual Dividend$0.87

Payout Ratio48.06%

FrequencyAnnual

Pay MonthsJun

Growth

3Y CAGR+4.74%

5Y CAGR+2.88%

FMS dividend history and ex-dividend dates Run FMS in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	9.45	EV/EBITDA	5.69x
Price/FCF	5.99x	FCF Yield	16.69%
Profitability
Profit Margin	4.22%	Operating Margin	9.63%
ROE	7.84%	ROIC	6.88%
Financial Health
Debt/Equity	0.59x	Interest Coverage	4.59x
Current Ratio	0.99x	Quick Ratio	0.69x
Trading Statistics
Beta	0.79	Avg Volume	1.38M
52-Week High	$26.42	52-Week Low	$19.24

Technical Indicators Dashboard

Moving Averages

SMA 10$22.81

SMA 20$22.30

SMA 50$22.34

SMA 200$22.54

EMA 10$22.82

EMA 20$22.55

EMA 50$22.53

EMA 200$22.98

MACD

Line: 0.25Signal: 0.10Hist: 0.16

ADX

ADX: 13.0+DI: 37.3-DI: 32.2

Aroon & PSAR

Aroon Up96.0

Aroon Down16.0

PSAR$21.90

Bollinger Bands

Upper Band$23.77

Lower Band$20.83

%B Position1318%(Upper)

Band Width0.87

RSI (14-Day)

Neutral

58.2

Momentum Oscillators

Stoch %K92.4

Stoch %D79.7

Williams %R-14.7

ROC (10d)3.2%

Momentum0.72

CCI (20d)119.7

MFI (14d)44.2

Volatility Measures

ATR (14d)$0.60(2.6%)

StdDev (20d)0.73

Hist Vol38.0%(Moderate)

Volume Flow

VWAP$23.34

OBV-4.1M

AD Line-337.5M

CMF (20d)0.103

Volume Metrics

Avg Vol (20d)1.4M

Vol Ratio0.8x

VWMA (20d)$22.18

Pivot Points

R3$24.28

R2$24.05

R1$23.86

Pivot Point$23.63

S1$23.44

S2$23.21

S3$23.02

Advanced Oscillators

TSI9.64

Ultimate Osc58.9

KST28.76

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$4.94B	$4.86B	$4.61B	$5.07B	$4.88B	$4.79B	$4.88B	$5.08B	$4.76B	$4.77B	$4.72B	$4.99B
Cost of Revenue	$3.66B	$3.55B	$3.43B	$3.68B	$3.64B	$3.58B	$3.70B	$3.81B	$3.61B	$3.60B	$3.55B	$3.64B
Gross Profit	$1.28B	$1.31B	$1.18B	$1.39B	$1.24B	$1.21B	$1.18B	$1.27B	$1.15B	$1.17B	$1.17B	$1.35B

Operating Expenses	$900.74M	$844.13M	$803.94M	$839.39M	$740.50M	$819.96M	$802.25M	$871.49M	$683.39M	$741.00M	$927.64M	$922.01M
R&D	$41.40M	$39.63M	$38.31M	$38.63M	$37.75M	$38.12M	$43.48M	$50.06M	$40.05M	$46.00M	$47.80M	$65.98M
SG&A	$587.82M	$736.01M	$601.40M	$727.35M	$519.32M	$607.73M	$594.20M	$644.89M	$555.82M	$580.03M	$585.08M	$845.16M
Operating Income	$374.64M	$465.86M	$375.56M	$548.98M	$501.72M	$394.40M	$381.73M	$398.93M	$462.70M	$425.00M	$246.01M	$427.65M

Interest Income	$16.05M	$14.70M	$14.62M	$13.62M	$19.16M	$21.85M	$14.98M	$21.57M	$16.93M	$18.00M	$15.66M	$26.87M
Interest Expense	$97.50M	$97.55M	$93.30M	$99.02M	$93.10M	$96.58M	$95.72M	$101.04M	$99.00M	$103.00M	$103.85M	$111.46M
Income Before Tax	$302.63M	$383.00M	$207.52M	$508.46M	$402.57M	$350.55M	$250.65M	$179.12M	$380.53M	$340.00M	$157.83M	$343.06M
Income Tax Expense	$77.83M	$89.83M	$42.75M	$106.44M	$75.22M	$78.26M	$61.05M	$61.00M	$116.53M	$99.00M	$39.51M	$86.46M

Net Income	$159.78M	$218.38M	$117.53M	$327.08M	$274.80M	$225.27M	$151.22M	$66.90M	$213.03M	$187.00M	$70.96M	$187.93M

EBITDA	$400.13M	$828.97M	$763.76M	$981.03M	$852.92M	$822.37M	$740.73M	$757.13M	$845.89M	$830.00M	$774.12M	$880.45M
EBIT	$400.13M	$465.86M	$300.82M	$607.48M	$495.66M	$447.13M	$346.37M	$280.13M	$479.63M	$443.00M	$261.68M	$454.51M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about FMS

News

Fresenius Medical Care stock faces tighter 2026 profit outlook

Fresenius Medical Care faces a tighter 2026 profit outlook after its third-quarter results, despite a 1% rise in revenue to 4.937 billion euros. Adjusted operating income declined 5%...

ad-hoc-news.de•Nov 6, 2026 7:30 AM ET11/6/26•Somewhat-Bearish

Fresenius Medical Care stock weighs narrower outlook against rollout gains

Fresenius Medical Care (FMC) has narrowed its 2026 operating-income outlook to flat to a negative mid-single-digit percentage change...

ad-hoc-news.de•Nov 5, 2026 1:01 PM ET11/5/26•Somewhat-Bearish

Fresenius Medical Care stock gains as profit outlook narrows

Fresenius Medical Care stock saw gains after reporting its third-quarter results, despite narrowing its 2026 operating-income outlook. While revenue slightly increased...

ad-hoc-news.de•Nov 5, 2026 5:51 AM ET11/5/26•Neutral

What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call

Fresenius Medical Care AG & Co. KGaA (FMS) reported broadly stable third-quarter revenue and a decline in operating income due to reimbursement pressures and inflation. The company is advancing its U.S. rollout...

TradingView•Nov 4, 2026 1:40 AM ET11/4/26•Somewhat-Bearish

Fresenius Medical Care stock slips as Q3 profit outlook narrows

Fresenius Medical Care's stock slipped after the company narrowed its 2026 profit outlook due to regulatory and inflation pressures affecting third-quarter earnings. Although revenue remained stable...

ad-hoc-news.de•Nov 3, 2026 1:06 PM ET11/3/26•Bearish

FMS Valuation and Fair Value

P/E: 9.5x
Forward P/E: 8.6x
EV/EBITDA: 5.7x
P/FCF: 6.0x
PEG: 0.7x
P/B: 0.8x

See GNG's fair value

FMS Profitability: Margins, ROIC and FCF

Gross margin: 26.5%
Operating margin: 9.6%
Net margin: 4.2%
ROIC: 6.9%
ROE: 7.8%
FCF margin: 7.9%
FCF yield: 16.7%

FMS Competitors

Company	Ticker
DaVita HealthCare Partners Inc	DVA
Elanco Animal Health	ELAN
Dr. Reddy’s Laboratories Ltd ADR	RDY
Universal Health Services Inc	UHS
Penumbra Inc	PEN
Bio-Techne Corp	TECH
Tempus AI, Inc. Class A Common Stock	TEM
Align Technology Inc	ALGN

Sector: Healthcare

FMS Analyst Ratings

Consensus: Sell
Analysts: 7
Strong Buy: 0
Buy: 1
Hold: 3
Sell: 1
Strong Sell: 2

FMS Bull Case vs Bear Case

Bull case

FMS beat EPS estimates in 75.0% of its last 8 reported quarters.

Bear case

42.9% of FMS's analyst ratings are Sell or Strong Sell.

FMS Earnings: Beat Rate and Next Report

Beat rate: 6 of 8 quarters (75.0%)
Average surprise: 12.8%
EPS estimate (fiscal period ending Dec 31, 2026): $0.55

FMS Dividend

Forward yield: 3.7%
Payout ratio: 48.1%
3Y DPS growth: 4.7%
5Y DPS growth: 2.9%
Pay months: Jun

FMS dividend history

FMS Earnings Call

The latest FMS earnings call transcript on file is labeled 2026Q2.

Read the 2026Q2 transcript

Frequently Asked Questions About FMS

When is FMS's next ex-dividend date?

FMS has not declared its next regular ex-dividend date yet. Its last ex-dividend date was May 22, 2026 ($0.8716 per share). Over the last 12 months, FMS went ex-dividend in May.

What is FMS's current dividend yield?

Fresenius Medical Care Corporation (FMS) has a forward dividend yield of 3.72%.

Does FMS pay dividends?

Yes, Fresenius Medical Care Corporation pays dividends with a forward dividend yield of 3.72%.

What is FMS's P/E ratio?

Fresenius Medical Care Corporation has a price-to-earnings (P/E) ratio of 9.45.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In